Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Zhejiang Jiuzhou Pharmaceutical Co., Ltd
  6. News
  7. Summary
    603456   CNE100001W36

ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD

(603456)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Ruibo Pharmaceutical Co., Ltd. announced that it has received CNY 280 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd

03/04/2021 EDT

On March 4, 2021, Ruibo (Suzhou) Pharmaceutical Co., Ltd. closed the transaction. The company completed the registration of the industrial and commercial change of capital increase and obtained a new "Business License" renewed by the Changshu Administrative Approval Bureau.


ę S&P Capital IQ 2021
All news about ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
09/22Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced that it expects to receive ..
CI
09/20ZHEJIANG JIUZHOU PHARMACEUTICAL CO., : 603456) added to S&P Global BMI Index
CI
09/20ZHEJIANG JIUZHOU PHARMACEUTICAL CO., : 603456) added to FTSE All-World Index
CI
08/11Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year End..
CI
04/27Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter..
CI
03/04Ruibo Pharmaceutical Technology Co., Ltd. announced that it has received CNY 32 million..
CI
03/04Ruibo Pharmaceutical Co., Ltd. announced that it has received CNY 280 million in fundin..
CI
02/09Ruibo Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 32 m..
CI
02/09Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced that it expects to receive ..
CI
02/09Ruibo Pharmaceutical Co., Ltd. announced that it expects to receive CNY 280 million in ..
CI
More news
Financials
Sales 2021 3 675 M 569 M 569 M
Net income 2021 614 M 95,0 M 95,0 M
Net Debt 2021 - - -
P/E ratio 2021 73,7x
Yield 2021 0,53%
Capitalization 45 144 M 6 988 M 6 989 M
Capi. / Sales 2021 12,3x
Capi. / Sales 2022 10,1x
Nbr of Employees 3 586
Free-Float 49,5%
Chart ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
Duration : Period :
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 54,30 CNY
Average target price 61,78 CNY
Spread / Average Target 13,8%
EPS Revisions
Managers and Directors
Zhi Hong Chen General Manager & Director
Yu Jie Sha Chief Financial Officer
Li Rong Hua Chairman
Meng Sheng Sun Chairman-Supervisory Board
Yuan Qiang Li Director-Technology, Research & Development
Sector and Competitors